173 results
Page 5 of 9
8-K
EX-4.3
v9irdp
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.2
txs2fecg
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-10.1
d2qdnqz fp
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.1
7o55alpb1ii
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
424B5
fjb gyksrrqcw8fct
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-1.1
mbbzg5s
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
6cy51c6v
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
0el4cgyladb
10 Jan 22
Prospectus supplement for primary offering
8:00am
8-K
EX-1.1
449nkg vzuob4a0cf
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-4.1
qqbeygf3ktfo10hh1t
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
424B5
dumjf
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
7jrevi
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
6oa ejc6yh
8 Jun 21
Submission of Matters to a Vote of Security Holders
4:35pm
DEFA14A
qvh4kfc 9soaz8p00ka
23 Apr 21
Additional proxy soliciting materials
4:33pm
8-K
EX-1.1
cfdxcslzwsx
18 Mar 21
Entry into a Material Definitive Agreement
5:13pm
424B5
du6flebz8jt
18 Mar 21
Prospectus supplement for primary offering
5:01pm
S-8
EX-23.2
9qzmq
18 Mar 21
Registration of securities for employees
7:30am